Medication Comparison

Wegovy vs Compounded Tirzepatide: Which Is Right for You?

A detailed side-by-side comparison of Wegovy and Compounded Tirzepatide, including cost, side effects, dosing, and provider availability.

At a Glance

Wegovy

FDA Approved
Novo Nordisk
semaglutide
Chronic weight management
$0/mo from
19Providers

Compounded Tirzepatide

Compounded
Various compounding pharmacies
tirzepatide
Not FDA-approved as a finished product
$65/mo from
16Providers

Detailed Comparison

FeatureWegovyCompounded Tirzepatide
Active Ingredientsemaglutidetirzepatide
ManufacturerNovo NordiskVarious compounding pharmacies
FDA ApprovedYesNo
FDA IndicationChronic weight managementNot FDA-approved as a finished product
Dosing ScheduleOnce weeklyOnce weekly
AdministrationSubcutaneous injection (pen)Subcutaneous injection (vial + syringe)
Starting Price (lowest provider)N/A$65/mo
Provider Count1916
Insurance Coverage12 providers2 providers
Weight Loss DataThe STEP 1 trial showed patients on Wegovy lost an average of 14.9% of body weight (about 33 lbs) over 68 weeks. In the STEP 3 trial, which combined W...As with compounded semaglutide, there are no large clinical trials on compounded tirzepatide specifically. Since it uses the same active ingredient as...

How They Compare

Wegovy and Compounded Tirzepatide represent two distinct approaches to GLP-1 based weight management. Wegovy contains semaglutide, a GLP-1 receptor agonist, while Compounded Tirzepatide contains tirzepatide, a dual GIP/GLP-1 receptor agonist. The dual mechanism of tirzepatide targets two incretin pathways simultaneously, which clinical trials suggest may produce greater average weight loss. However, both medications have proven effective, and the best choice depends on individual factors including insurance coverage, side effect tolerance, and provider availability.

Side Effects Comparison

Wegovy

Common

  • Nausea (44% of patients, usually temporary)
  • Diarrhea (30%)
  • Vomiting (24%)
  • Constipation (24%)
  • Abdominal pain
  • Headache
  • Fatigue

Serious (Rare)

  • Pancreatitis
  • Gallbladder problems
  • Kidney injury
  • Suicidal thoughts (rare, under investigation)
  • Thyroid C-cell tumors (boxed warning, animal studies)
  • Hypoglycemia when combined with insulin

Compounded Tirzepatide

Common

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion
  • Abdominal pain

Serious (Rare)

  • Same serious risks as brand-name tirzepatide
  • Pancreatitis
  • Gallbladder problems
  • Kidney injury
  • Thyroid C-cell tumors (theoretical risk)
  • Quality concerns with compounding

Dosing Schedule Comparison

Wegovy

Subcutaneous injection (pen) - Once weekly

1
0.25 mg
Month 1 - Weeks 1-4
2
0.5 mg
Month 2 - Weeks 5-8
3
1 mg
Month 3 - Weeks 9-12
4
1.7 mg
Month 4 - Weeks 13-16
5
2.4 mg
Maintenance - Week 17+

Compounded Tirzepatide

Subcutaneous injection (vial + syringe) - Once weekly

1
2.5 mg
Initiation - Weeks 1-4
2
5 mg
Escalation - Weeks 5-8
3
7.5 mg
Escalation - Weeks 9-12
4
10 mg
Escalation - Weeks 13-16
5
12.5 mg
Escalation - Weeks 17-20
6
15 mg
Maintenance - Week 21+

Frequently Asked Questions

What is the difference between Wegovy and Compounded Tirzepatide?

Wegovy (Semaglutide) is made by Novo Nordisk and is FDA-approved. Compounded Tirzepatide (Tirzepatide (compounded)) is made by Various compounding pharmacies and is not FDA-approved as a finished product. Wegovy uses semaglutide (a GLP-1 agonist) while Compounded Tirzepatide uses tirzepatide (a dual GIP/GLP-1 agonist), which may produce different weight loss results.

Which is more affordable, Wegovy or Compounded Tirzepatide?

Based on available providers, Wegovy starts at $0/month while Compounded Tirzepatide starts at $65/month. Wegovy is the more affordable starting option. Actual costs depend on your provider, insurance coverage, and dose level.

Which is more effective for weight loss, Wegovy or Compounded Tirzepatide?

Both medications have shown significant weight loss results. Clinical trials suggest tirzepatide (dual GIP/GLP-1 agonist) may produce slightly greater average weight loss than semaglutide (GLP-1 agonist alone), though individual results vary significantly. Your healthcare provider can help determine which is best for your specific situation.

Can I switch from Wegovy to Compounded Tirzepatide?

Switching between GLP-1 medications is possible but should always be done under medical supervision. Your provider will determine the appropriate starting dose for the new medication and may adjust the transition schedule based on your current dose and response. Since these medications use different active ingredients, your provider may need to restart the dose escalation process.

Find Wegovy Providers

Compare providers offering Wegovy near you

Find Providers

Find Compounded Tirzepatide Providers

Compare providers offering Compounded Tirzepatide near you

Find Providers

Related Comparisons

Medical Disclaimer: This comparison is for educational purposes only and should not replace professional medical advice. Individual results vary. Always consult your healthcare provider before starting or changing any medication.